Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Analysis of the Association of Drug Activity Measured in Viable Tumour Tissues ex Vivo and Clinical Response in Acute Myeloid Leukaemia (EXCYTE-2)

NCT06648512 is registered in ClinicalTrials.gov with Exscientia AI Limited as lead sponsor.

NCT NCT06648512
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06648512 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Analysis of the Association of Drug Activity Measured in Viable Tumour Tissues ex Vivo and Clinical Response in Acute Myeloid Leukaemia (EXCYTE-2)
Lead sponsor
Exscientia AI Limited
Phase
Observational
Overall status
Completed
Start date
May 13, 2024
Completion date
March 7, 2025
Enrollment
91 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

acute myeloid leukemia (aml), acute myeloid leukemia (aml) relapse